Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8686443 | Neurobiology of Disease | 2018 | 40 Pages |
Abstract
rGas6 reduced the neurological deficits by inhibiting neuroinflammation via the TLR/TRAF/NF-κB signaling pathway. rGas6 can be used as potential treatment to ischemic stroke.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Guangyong Wu, Devin W. McBride, John H. Zhang,